GESOX
Price
$17.86
Change
-$0.00 (-0.00%)
Updated
May 9 closing price
Net Assets
84.62M
RNPEX
Price
$62.30
Change
+$0.12 (+0.19%)
Updated
May 9 closing price
Net Assets
142.07B
Ad is loading...

GESOX vs RNPEX

Header iconGESOX vs RNPEX Comparison
Open Charts GESOX vs RNPEXBanner chart's image
Lazard Global Equity Select Port Open
Price$17.86
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets84.62M
American Funds New Perspective R4
Price$62.30
Change+$0.12 (+0.19%)
VolumeN/A
Net Assets142.07B
GESOX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GESOX vs. RNPEX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GESOX is a Buy and RNPEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 142B vs. GESOX (84.6M). RNPEX pays higher dividends than GESOX: RNPEX (0.55) vs GESOX (0.29). GESOX was incepted earlier than RNPEX: GESOX (11 years) vs RNPEX (23 years). GESOX (1.57) is less costly to investors than RNPEX (0.76). RNPEX (24.00) and GESOX (23.00) have comparable annual turnover. RNPEX has a lower initial minimum investment than GESOX: RNPEX (250) vs GESOX (2500). RNPEX annual gain was more profitable for investors over the last year : 5.27 vs. GESOX (-4.88). RNPEX return over 5 years is better than : 46.39 vs. GESOX (37.97).
GESOXRNPEXGESOX / RNPEX
Total Expense Ratio1.150.76151%
Annual Report Gross Expense Ratio1.570.76207%
Fund Existence11 years23 years-
Gain YTD-2.0832.282-91%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets84.6M142B0%
Annual Yield % from dividends0.290.5554%
Returns for 1 year-4.885.27-93%
Returns for 3 years19.1027.4170%
Returns for 5 years37.9746.3982%
Returns for 10 years68.9164.04108%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALZN0.660.12
+21.87%
Alzamend Neuro Inc.
REPL7.71-0.06
-0.77%
Replimune Group
ASGN55.69-0.73
-1.29%
ASGN
TOI2.80-0.12
-4.11%
Oncology Institute (The)
AFRM46.41-7.85
-14.47%
Affirm Holdings